Getlabs

Overview
News
Hospital-at-Home?
Product stageSegments
Go-to-Market
?
Lab Diagnostics and Screening
?

Getlabs is a leading provider of at-home diagnostic collections, offering a nationwide infrastructure for remote healthcare delivery. Founded in 2018, the company connects certified phlebotomists with patients to perform lab tests in the comfort of their homes or offices. Getlabs collects blood, saliva, stool, urine, and breath samples, and can also measure vital signs and biometrics. The company works with major diagnostic laboratories, including Labcorp, Quest Diagnostics, and Sonora Quest, to process the collected samples.

Getlabs' service starts at a convenience fee of USD 25 for day-of appointments, with prices increasing to between USD 49 and USD 59 for later appointments. This pricing model is significantly lower than independent phlebotomists, who can charge between USD 75 and USD 150. As of 2023, Getlabs' network of phlebotomists covers approximately 45% of the US population, primarily serving suburban areas. The company aims to reach 60% coverage by the end of the year.

In addition to its consumer-facing service, Getlabs has developed an API that allows healthcare organizations to integrate at-home lab appointments directly into their platforms. This enables telehealth providers to expand their services beyond simple conditions to more complex areas such as cardiology, diabetes, and fertility care. By bridging the gap between virtual and in-person care, Getlabs aims to unlock the full potential of telehealth.

Key customers and partnerships

Getlabs has established partnerships with several major healthcare companies. In April 2022, Labcorp launched "Getlabs for Labcorp," a service that combines Labcorp's diagnostic tests with Getlabs' phlebotomy service. This collaboration makes Labcorp's full range of tests, including advanced tests like liquid biopsies for cancer, available for at-home collection in 50 US markets.

In May 2023, Getlabs partnered with Nice healthcare, an in-home and virtual primary care clinic, to expand access to in-home healthcare services and lab testing. This partnership aims to provide patients with a more personalized and cost-effective healthcare experience.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Miami FL USA
Founded year:
2018
Employees:
251-500
IPO status:
Private
Total funding:
USD 40.0 mn
Last Funding:
USD 20.0 mn (Series A; Feb 2022)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.